Apex Critical Mtals (APXCF) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 4, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 40-F for FY2026, filed Oct 29, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the APXCF SEC filings page.
This page shows Apex Critical Mtals Corp (APXCF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (40-F and 6-K reports).
Financial Health Signals
We do not publish a peer-relative financial health score for Apex Critical Mtals Corp, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
Apex Critical Mtals Corp reported a net loss of $10.0M while operations used $3.5M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Apex Critical Mtals Corp reported a net loss of $10.0M in fiscal year 2026.
Apex Critical Mtals Corp earned -$0.13 per diluted share (EPS) in fiscal year 2026.
Not reported for fiscal year 2026.
Not reported for fiscal year 2026.
Cash & Balance Sheet
Apex Critical Mtals Corp held $10.7M in cash as of fiscal year 2026; no long-term debt figure is on record for that period.
Not reported for fiscal year 2026.
Not reported for fiscal year 2026.
Margins & Returns
Apex Critical Mtals Corp's ROE was -41.7% in fiscal year 2026, measuring profit generated per dollar of shareholder equity.
Not reported for fiscal year 2026.
Not reported for fiscal year 2026.
Not reported for fiscal year 2026.
Capital Allocation
None of these metrics is reported for fiscal year 2026.
APXCF Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2640-F |
|---|---|
| Operating Income | -$10.3M |
| Net Income | -$10.0M |
| EPS (Basic) | -$0.13 |
| EPS (Diluted) | -$0.13 |
| Diluted Shares (Avg) | 77M |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, EBITDA, Interest Expense, Income Tax.
APXCF Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2640-F |
|---|---|
| Total Assets | $26.9M |
| Current Assets | $11.5M |
| Cash & Equivalents | $10.7M |
| Accounts Receivable | $168K |
| Total Liabilities | $3.0M |
| Current Liabilities | $3.0M |
| Non-Current Liabilities | $0 |
| Total Equity | $23.9M |
| Retained Earnings | -$14.1M |
Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Long-Term Investments, Goodwill, Long-Term Debt.
APXCF Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2640-F |
|---|---|
| Operating Cash Flow | -$3.5M |
| Investing Cash Flow | -$11.0M |
| Financing Cash Flow | $21.3M |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
APXCF Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2640-F |
|---|---|
| Return on Equity | -41.7% |
| Return on Assets | -37.1% |
| Current Ratio | 3.85 |
| Liabilities-to-Equity | 0.12 |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Debt-to-Equity, Asset Turnover, FCF Margin.
Where Apex Critical Mtals Corp Ranks
Frequently Asked Questions
No, Apex Critical Mtals Corp (APXCF) reported a net loss of $10.0M in fiscal year 2026.
Apex Critical Mtals Corp (APXCF) has a return on equity of -41.7% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
Apex Critical Mtals Corp (APXCF) recorded an outflow of $3.5M in operating cash flow during fiscal year 2026, representing cash used by core business activities.
Apex Critical Mtals Corp (APXCF) had $26.9M in total assets as of fiscal year 2026, including both current and long-term assets.
Apex Critical Mtals Corp (APXCF) had a current ratio of 3.85 as of fiscal year 2026, which is generally considered healthy.
Apex Critical Mtals Corp (APXCF) had a liabilities-to-equity ratio of 0.12 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2026, because the filing data we hold for that year carries no long-term debt figure.
Apex Critical Mtals Corp (APXCF) had a return on assets of -37.1% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
Apex Critical Mtals Corp (APXCF) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2026). The market capitalization is $79.4M as of Nov 4, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Apex Critical Mtals Corp (APXCF) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $79.4M as of Nov 4, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Apex Critical Mtals Corp (APXCF) reported a net loss of $10.0M while operations used $3.5M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.